FYI Digest Newsletter Back Issues 26. Program supports iterative product development and optimization in the later stages of vaccine research and includes limited human studies. Research directed toward optimization of existing vaccine concepts is also encouraged.
Applications can include preclinical research, vaccine production, and clinical testing.
Applicants must delineate discrete goals, milestones, and criteria that can be used to evaluate progress toward a testable vaccine. Program project grant P01 applications may be submitted in response to this announcement. The total project period may not exceed five years. All applications in response to this PA must include detailed rather than modular budgets.